pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
IRINOTECAN HYDROCHLOIDE
IRINOTECAN HYDROCHLOIDE (IRINOTECAN HYDROCHLOIDE)
GLAND
0
catalysts
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
0
catalysts
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
0
catalysts
Phase 2
IRX-4204
Parkinson's Disease
Retinoid X receptor
← prev
page 97 of 231
next →
131
Pain
89
Neurology
1
Io Therapeutics Inc
0
catalysts
Preclinical
IS-101
InvisiMask
Coronavirus Disease 2019 (COVID-19)
InvisiShield Technologies Ltd
0
catalysts
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
0
catalysts
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
0
catalysts
Preclinical
ISM-9274
Solid Tumor
InSilico Medicine
0
catalysts
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
0
catalysts
ISOLYTE S PH 7.4
ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE)
B BRAUN
0
catalysts
Phase 2
ISP-001
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Immusoft Corp
0
catalysts
Preclinical
ISP-002
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Immusoft Corp
0
catalysts
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
0
catalysts
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
0
catalysts
Preclinical
ITR-2401
Androgenic Alopecia
Solipharma LLC
0
catalysts
IVABRADINE
IVABRADINE (IVABRADINE)
ANNORA PHARMA
0
catalysts
Phase 2
IVB-001
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Invictus Therapeutics Ltd
0
catalysts
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
0
catalysts
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
0
catalysts
IVRA
IVRA (MELPHALAN HCL)
APOTEX
0
catalysts
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
0
catalysts
Preclinical
IVT-8086
Osteosarcoma
Innova Therapeutics Inc
0
catalysts
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
0
catalysts
Preclinical
IVW-1802
Myopia
iView Therapeutics Inc
0
catalysts
Preclinical
IXTV-100
Substance (Drug) Abuse
InterveXion Therapeutics LLC
0
catalysts
Marketed
Iheezo
Iheezo (chloroprocaine [INN])
Local Anesthetic Effect
$HROW
HARROW, INC.
0
catalysts
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
0
catalysts
